- Home
- TSVT vs NRO Comparison
TSVT vs NRO Comparison
Compare TSVT & NRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSVT
- NRO
- Stock Information
- Founded
- TSVT 2021
- NRO 2003
- Country
- TSVT United States
- NRO United States
- Employees
- TSVT N/A
- NRO N/A
- Industry
- TSVT Biotechnology: Pharmaceutical Preparations
- NRO Finance/Investors Services
- Sector
- TSVT Health Care
- NRO Finance
- Exchange
- TSVT Nasdaq
- NRO Nasdaq
- Market Cap
- TSVT 160.4M
- NRO 187.8M
- IPO Year
- TSVT N/A
- NRO N/A
- Fundamental
- Price
- TSVT $3.16
- NRO $3.80
- Analyst Decision
- TSVT Buy
- NRO
- Analyst Count
- TSVT 6
- NRO 0
- Target Price
- TSVT $10.40
- NRO N/A
- AVG Volume (30 Days)
- TSVT 339.4K
- NRO 239.4K
- Earning Date
- TSVT 11-12-2024
- NRO 01-01-0001
- Dividend Yield
- TSVT N/A
- NRO 11.41%
- EPS Growth
- TSVT N/A
- NRO N/A
- EPS
- TSVT N/A
- NRO N/A
- Revenue
- TSVT $45,620,000.00
- NRO N/A
- Revenue This Year
- TSVT N/A
- NRO N/A
- Revenue Next Year
- TSVT $31.98
- NRO N/A
- P/E Ratio
- TSVT N/A
- NRO N/A
- Revenue Growth
- TSVT N/A
- NRO N/A
- 52 Week Low
- TSVT $1.68
- NRO $2.51
- 52 Week High
- TSVT $6.40
- NRO $3.45
- Technical
- Relative Strength Index (RSI)
- TSVT 24.53
- NRO 43.35
- Support Level
- TSVT $4.81
- NRO $3.71
- Resistance Level
- TSVT $5.12
- NRO $3.84
- Average True Range (ATR)
- TSVT 0.31
- NRO 0.09
- MACD
- TSVT -0.16
- NRO -0.01
- Stochastic Oscillator
- TSVT 6.67
- NRO 31.48
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. The fund invests in sectors, such as apartments, Data Centers, Infrastructure REITs, Manufactured Homes, Office, Regional Malls and others.